Government and Institutional Procurement Marketing
Moderna's primary commercial channel for its vaccine products is government and institutional procurement — engaging national health authorities, ministries of health, and supranational bodies like COVAX and CEPI through direct negotiations rather than consumer-facing advertising. This B2G (business-to-government) marketing approach requires deep relationships with public health decision-makers and scientific credibility with regulatory agencies rather than traditional consumer marketing.
Scientific Publication and Conference Leadership
Moderna systematically publishes clinical trial results in high-impact peer-reviewed journals and presents at major scientific conferences — ASH, ASCO, AACR, ISVA — building scientific credibility that influences both regulatory outcomes and physician adoption of its products. Scientific leadership in mRNA platform development creates earned media coverage that amplifies brand awareness beyond what paid advertising could achieve.